Citius Pharmaceuticals Share Price (NASDAQ: CTXR)
$1.23
Last updated on
Check the interactive Citius Pharmaceuticals Stock chart to analyse performance
Citius Pharmaceuticals stock performance
as on August 20, 2025 at 8:34 PM IST
- Today's Low:$1.23Today's High:$1.40
0.41%
Downside
Day's Volatility :12.5%
Upside
12.14%
- 52 Weeks Low:$0.6552 Weeks High:$17.00
47.15%
Downside
52 Weeks Volatility :96.18%
Upside
92.77%
Citius Pharmaceuticals Stock Returns
Citius Pharmaceuticals Inc Key Stats
Check Citius Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Citius Pharmaceuticals Stock including INR - Dollar returns
The Citius Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Citius Pharmaceuticals investment value today
Current value as on today
₹11,944
Returns
Returns from Citius Pharmaceuticals Stock
Dollar Returns*
₹3,788 (+3.79%)
Indian investors sentiment towards Citius Pharmaceuticals Stock
Global Institutional Holdings in Citius Pharmaceuticals Inc
Name
Holdings %
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
1.27%
Geode Capital Management, LLC
0.62%
Vanguard Group Inc
0.55%
BlackRock Inc
0.50%
UBS Group AG
0.46%
Squarepoint Ops LLC
0.42%
Analyst Recommendation on Citius Pharmaceuticals Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Citius Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Citius Pharmaceuticals Share Price Target
What analysts predicted
Upside of 387.8%
Target:
$6.00
Current:
$1.23
Citius Pharmaceuticals share price target is $6.00, a slight Upside of 387.8% compared to current price of $1.23 as per analysts' prediction.
Citius Pharmaceuticals Stock Insights
Price Movement
In the last 3 months, CTXR stock has moved up by 65.2%CTXR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 155.2%CTXR vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.3% return, outperforming this stock by 208.2%
Citius Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Citius Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Citius Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -15.28% | -43.26% | -91.91% | -96.0% | -95.17% |
 | 4.65% | -16.73% | -52.11% | -6.73% | -5.71% |
 | 7.16% | 32.17% | 61.08% | 80.84% | 30.07% |
 | -14.79% | -17.19% | -19.84% | 32.96% | 44.01% |
 | 43.03% | 83.01% | 63.29% | 110.39% | 235.62% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | -2.08 | -0.55 | -0.23 | NA | 4.5 |
| 14.47 | 14.47 | 1.18 | 39.36 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.33 | -0.05 | -0.01 | NA | 34.32 |
| 27.73 | 27.73 | 0.58 | 18.04 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $23.5M | -95.17% | NA | 0.0% |
| Buy | $60.8B | -5.71% | 14.47 | 31.37% |
| NA | $39.3B | 30.07% | NA | -3.89% |
| Buy | $100.0B | 44.01% | 27.73 | 31.86% |
| Buy | $58.8B | 235.62% | NA | -12.96% |
About Citius Pharmaceuticals Inc
Key Management of Citius Pharmaceuticals Inc
Important FAQs about investing in CTXR Stock from India :
What is Citius Pharmaceuticals share price today?
Citius Pharmaceuticals share price today is $1.23 as on at the close of the market. Citius Pharmaceuticals share today touched a day high of $1.40 and a low of $1.23.
What is the 52 week high and 52 week low for Citius Pharmaceuticals share?
Citius Pharmaceuticals share touched a 52 week high of $17.00 and a 52 week low of $0.65. Citius Pharmaceuticals stock price today i.e. is closed at $1.23, lower by 92.77% versus the 52 week high.
How to invest in Citius Pharmaceuticals Stock (CTXR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Citius Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Citius Pharmaceuticals Shares that will get you 1.2195 shares as per Citius Pharmaceuticals share price of $1.23 per share as on August 20, 2025 at 8:34 PM IST.
What is the minimum amount required to buy Citius Pharmaceuticals Stock (CTXR) from India?
Indian investors can start investing in Citius Pharmaceuticals (CTXR) shares with as little as ₹86.938 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹869.38 in Citius Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 20, 2025).
Based on Citius Pharmaceuticals share’s latest price of $1.23 as on August 20, 2025 at 8:34 PM IST, you will get 8.1301 shares of Citius Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Citius Pharmaceuticals has given to Indian investors in the last 5 years?
Citius Pharmaceuticals stock has given -95.17% share price returns and 16.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Ishares Msci Peru And Global Exposure Etf$51.59
-1.51%
Naas Technology Inc$2.94
-1.34%
Brt Apartments Corp$15.28
+1.46%
Fidelity International Multifactor Etf$32.87
-0.09%
Blackrock Muniyield Qual Ii$9.51
-0.42%
- Pmv Adaptive Risk Parity Etf
$28.89
-0.58%
Invesco Db Precious Metals Fund$75.54
-0.92%
- Lobo Ev Technologies Ltd
$0.60
-6.25%
Magyar Bancorp Inc$17.48
+1.33%